Patient info Search Menu

Constella 290 micrograms hard capsules – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
290 micrograms
Contains active substance:

Patient leaflet - Constella 290 micrograms hard capsules

1. What Constella is and what it is used for

What Constella is used for

Constella contains the active substance linaclotide. It is used to treat the symptoms of moderate to severe irritable bowel syndrome (often just called “IBS”) with constipation in adult patients.

IBS is a common gut disorder. The main symptoms of IBS with constipation include:

  • stomach or abdominal pain,
  • feeling bloated,
  • infrequent, hard, small or pellet-like stools

    (faeces).

These symptoms may vary from person to person.

How Constella works

Constella acts locally in your gut, helping you to feel less pain and less bloated, and to restore the normal functioning of your bowels. It is not absorbed into the body, but attaches to receptor called guanylate cyclase C on the surface of your gut. By attaching to this receptor, it blocks the

sensation of pain and allows liquid to enter from the body into the gut, thereby loosening the stools and increasing your bowel movements.

2. What you need to know before you take Constella

Do not take Constella

  • if you are allergic to linaclotide or any of the

    other ingredients of this medicine (listed in section 6).

  • if you or your doctor know that you have

    a blockage in your stomach or bowels.

Warnings and precautions

Your doctor has given this medicine to you after excluding other diseases, especially of your bowels and concluding that you suffer from IBS with constipation. Because these other diseases may have the same symptoms as IBS, it is important that you report any change or irregularity in symptoms to your doctor promptly.

If you experience severe or prolonged diarrhoea (passing of frequent watery stools for 7 days or more), stop taking Constella and contact your doctor (see section 4). Make sure you drink plenty of fluids to replace the water and electrolytes like potassium lost from the diarrhoea.

If you have severe stomach symptoms which continue or get worse, stop taking Constella and contact your doctor immediately because these could be symptoms of a hole developing in the bowel wall (gastrointestinal perforation). See section 4.

Talk to your doctor if you experience bleeding from the bowel or rectum.

Take special care if you are older than 65 years, as there is a higher risk you experience diarrhoea.

Take also special care if you have severe or prolonged diarrhoea and an additional disease, such as high blood pressure, previous disease of the heart and blood vessels (e.g. such as previous heart attacks) or diabetes.

Talk to your doctor if you suffer from inflammatory diseases of the guts such as Crohn’s disease or ulcerative colitis as Constella is not recommended in these patients.

Children and adolescents

Do not give this medicine to children and adolescents under the age of 18 years because the safety and efficacy of Constella in this age group has not been established.

Other medicines and Constella

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines:

  • Some medicines may not work as effectively if you have severe or prolonged diarrhoea, such as:

    • Oral contraceptives. If you have very

      bad diarrhoea, the contraceptive pill may not work properly and the use of an extra method of contraception is recommended. See the instructions in the patient leaflet of the contraceptive pill you are taking.

    • Medicines that need careful and exact

      dosing, such as levothyroxine (a hormone to treat reduced function of the thyroid gland).

      • Some medicines may increase the risk of diarrhoea when taken with Constella, such as:

        • Medicines to treat stomach ulcers or

          excessive production of stomach acid called Proton Pump Inhibitors.

        • Medicines to treat pain and inflammation

          called NSAIDs.

        • Laxatives.

Constella with food

Constella produces more frequent bowel movements and diarrhoea (looser stools) when it is taken with food than when it is taken on an empty stomach (see section 3).

Pregnancy and breast-feeding

Limited information is available on the effects of Constella in pregnant and breast-feeding women.

Do not take this medicine if you are pregnant, think you may be pregnant or are planning to have a baby, unless your doctor advises you to do so.

In a milk-only lactation study in seven lactating women, who were already taking linaclotide therapeutically, neither linaclotide nor its active metabolite were detected in the milk. Therefore breastfeeding is not expected to result in exposure of the infant to linaclotide and Constella can be used during breast-feeding.

Driving and using machines

Constella will not affect your ability to drive or use machines

3. How to take Constella

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is one capsule (i.e. 290 micrograms of linaclotide) taken orally once a day. The capsule should be taken at least 30 minutes before a meal.

If you have not experienced improvement in your symptoms after 4 weeks of treatment, you should contact your doctor.

If you take more Constella than you should

The most likely effect of taking too much Constella is diarrhoea. Contact your doctor or pharmacist if you have taken too much of this medicine.

If you forget to take Constella

Do not take a double dose to make up for a forgotten dose. Just take the next dose at the scheduled time and continue as normal.

If you stop taking Constella

It is preferable to discuss stopping treatment with your doctor before actually doing so. However, treatment with Constella can be safely stopped at any time.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects:

Stop using Constella and seek medical attention immediately if you experience any of the following symptoms: difficulty breathing, light-headedness, fainting, fast heartbeat, swelling of the face, throat, or other parts of the body and sweating. These could be signs of an

anaphylactic reaction (sudden, severe allergic reaction) (not known: frequency cannot be estimated from the available data).

Very common (may affect more than 1 in 10 people):

  • diarrhoea

Diarrhoea is normally short lived; however, if you experience severe or prolonged diarrhoea (passing of frequent watery stools for 7 days or more) and feel lightheaded, dizzy or faint, stop taking Constella and contact your doctor.

Common (may affect up to 1 in 10 people):

  • stomach or abdominal pain
  • feeling bloated
  • wind
  • stomach flu (viral gastroenteritis)
  • feeling dizzy

Uncommon (may affect up to 1 in 100 people):

  • lack of control over passing stools (faecal

    incontinence)

  • urgency to pass stools
  • feeling lightheaded after standing

    up quickly

  • dehydration
  • low level of potassium in your blood
  • decreased appetite
  • rectal bleeding
  • bleeding from the bowel or

    rectum including bleeding from piles/haemorrhoids

  • nausea
  • vomiting
  • hives (urticaria)

Rare (may affect up to 1 in 1 000 people):

  • bicarbonate decrease in your blood
  • a hole developing in the bowel wall

    (gastrointestinal perforation)

Not known (frequency cannot be estimated from the available data):

  • rash

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Constella

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the bottle after ¨EXP¨. The expiry date refers to the last day of that month.

Once the bottle is opened, the capsules should be used within 18-weeks.

Do not store above 30°C. Keep the bottle tightly closed in order to protect from moisture.

Warning: The bottle contains one or more sealed canisters containing silica gel to keep the capsules dry. Keep the canisters in the bottle. Do not swallow them.

Do not use this medicine if you notice any signs of damage to the bottle or any change in the appearance of the capsules.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Constella contains

  • The active substance is linaclotide. Each capsule contains 290 micrograms of linaclotide.
  • The other ingredients are :

Capsule content: microcrystalline cellulose, hypromellose, calcium chloride dihydrate and leucine.

Capsule shell: red iron oxide (E172), titanium dioxide (E171), yellow iron oxide (E172), gelatin and polyethylene glycol.

Capsule ink: shellac, propylene glycol, concentrated ammonia solution, potassium hydroxide, titanium dioxide (E171) and black iron oxide (E172).

What Constella looks like and contents of the pack

The capsules are white to off-white-orange opaque hard capsules marked “290” with grey ink.

They are packaged in a white, high density polyethylene (HDPE) bottle with a tamper evident seal and a child-resistant screw cap, together with one or more desiccant canisters containing silica gel.

Constella is available in packs containing 10, 28 or 90 capsules and in multipacks of 112 capsules comprising 4 cartons, each containing 28 capsules. Not all pack-sizes may be marketed.

Marketing Authorisation Holder

AbbVie Ltd.

Maidenhead

SL6 4UB

UK

Tel: +44 (0)1628 561090

Manufacturer

Forest Laboratories Ireland Limited

Clonshaugh Business and Technology Park Clonshaugh,

Dublin 17, D17 E400

Ireland

This leaflet was last revised in

June 2026

To listen to or request a copy of this leaflet in Braille, large print or audio, please contact the Marketing Authorisation Holder. Constella

290 micrograms

hard capsules

linaclotide

PX3932/1 PX3932/1

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 41042/0079

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Constella 290 micrograms hard capsules

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Linaclotide
Strength? 290 micrograms
Pharmaceutical form? Oral capsule
White to off-white-orange opaque capsule (18 mm x 6.35 mm) marked “290” with grey ink.
How is it taken? Oral
Excipients? Microcrystalline cellulose Hypromellose 4-6 mPa’s – substitution type 2910 Calcium chloride dihydrate Leucine, Titanium dioxide (E 171) Gelatin, Red iron oxide (E172), Yellow iron oxide (E172) Polyethylene glycol, Shellac, Propylene glycol, Concentrated ammonia solution Potassium hydroxide, Titanium dioxide (E 171) Black iron oxide (E172)
Pack sizes 28 capsule
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? Unopened bottle for 28, 90 and multipack containing 112 (4 packs of 28) capsules: 3 years.
Unopened bottle for 10 capsules: 2 years.
After first opening: 18 weeks.
Storage Do not store above 30 °C. Keep the bottle tightly closed in order to protect from moisture.
The bottle contains one or more sealed canisters containing silica gel to keep the capsules dry. Keep the canisters in the bottle.
Drug group (ATC)? Drugs for constipation, other drugs for constipation
  1. A Alimentary tract and metabolism drugs
    1. A06 Drugs for constipation
      1. A06A Drugs for constipation
        1. A06AX Other drugs for constipation
          1. A06AX04 linaclotide
Marketing authorisation? PLGB 41042/0079 (first authorised 26 November 2012)
Marketing authorisation holder? AbbVie Ltd.
Codes? GTIN 5016007205435 · BNF 01060700

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.0.0 of 2 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.